Literature DB >> 11687578

Cloning and characterization of liver-specific isoform of Chk1 gene from rat.

Y J Shann1, M T Hsu.   

Abstract

We have isolated and characterized an isoform of protein kinase Chk1 gene from rat liver and a rat liver cDNA library by 5'-rapid amplification of cDNA ends. The gene (Cil) contains the C-terminal region of the Chk1 gene, but the 5'-end is derived from a sequence in the intron of Chk1 preceding the C-terminal domain by differential RNA splicing. The kinase domain of Chk1 gene is absent in this isoform. Tissue RNA and protein blot analyses indicated that Cil was specifically expressed only in rat liver, and its expression increased with liver development. Expression of Cil was found to be reduced in three rat hepatoma cell lines examined. A promoter trap experiment suggested that a promoter was located in the intron preceding the C-terminal domain of Chk1, and transcription from this novel promoter generated the new 5' noncoding exon of Cil. Thus Cil was generated by both alternate promoter usage and differential RNA splicing. UV irradiation induced caffeine-sensitive phosphorylation of both Chk1 and Cil at Ser-345 in Chk1 and its equivalent site in Cil, implying a role for ATR kinase in the phosphorylation of both proteins. We demonstrated the interaction between the kinase domain of Chk1 and Cil using a yeast two-hybrid assay and pull-down technique. In contrast to the effect of Chk1, Cil was found to decrease the transactivating function of p53, and the S63A mutation of Cil abolished this effect. These results suggest that Cil may serve as a dominant negative competitor of Chk1 as suggested previously.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687578     DOI: 10.1074/jbc.M108253200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation.

Authors:  Yoshinori Katsuragi; Noriyuki Sagata
Journal:  Mol Biol Cell       Date:  2004-02-06       Impact factor: 4.138

Review 2.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

3.  The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress.

Authors:  You-Wei Zhang; John Brognard; Chris Coughlin; Zhongsheng You; Marisa Dolled-Filhart; Aaron Aslanian; Gerard Manning; Robert T Abraham; Tony Hunter
Journal:  Mol Cell       Date:  2009-08-28       Impact factor: 17.970

4.  BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrest.

Authors:  Ronit I Yarden; Sally Metsuyanim; Itay Pickholtz; Shabana Shabbeer; Hadass Tellio; Moshe Z Papa
Journal:  Int J Biochem Cell Biol       Date:  2012-06-26       Impact factor: 5.085

5.  Conformational Change of Human Checkpoint Kinase 1 (Chk1) Induced by DNA Damage.

Authors:  Xiangzi Han; Jinshan Tang; Jingna Wang; Feng Ren; Jinhua Zheng; Megan Gragg; Philip Kiser; Paul S H Park; Krzysztof Palczewski; Xinsheng Yao; Youwei Zhang
Journal:  J Biol Chem       Date:  2016-04-18       Impact factor: 5.157

Review 6.  Checkpoint kinase 1 in DNA damage response and cell cycle regulation.

Authors:  Mallikarjun Patil; Navjotsingh Pabla; Zheng Dong
Journal:  Cell Mol Life Sci       Date:  2013-03-19       Impact factor: 9.261

Review 7.  Pushing the limits of the scanning mechanism for initiation of translation.

Authors:  Marilyn Kozak
Journal:  Gene       Date:  2002-10-16       Impact factor: 3.688

8.  Importance of a C-terminal conserved region of Chk1 for checkpoint function.

Authors:  Carmela Palermo; Justin C Hope; Greg A Freyer; Hui Rao; Nancy C Walworth
Journal:  PLoS One       Date:  2008-01-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.